CC

Cancer Communications

Cancer Communications is an open access, peer-reviewed online journal published in association with Sun Yat-sen University Cancer Center, covering basic, clinical, and translational cancer research, including clinical trials, epidemiology, molecular and cellular biology, and genetics.

Looking to publish in Cancer Communications? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 24.9
Quartile Q1
Open Access Type Open
eISSN 2523-3548
Invitation Only No

Submission Instructions

Cancer Communications accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter A cover letter is required for submission. Cover letter must include the paper title, a brief summary of the main point, a statement that the material has not been published or submitted elsewhere, confirmation that all authors have reviewed and agree to the publication ethics policies, names email addresses and ORCID IDs for all authors with one corresponding author identified, and any use of AI-assisted technologies should be noted.
Abstract Original Articles must include an abstract. Abstract must be no more than 350 words.
Manuscript Original Articles are encouraged to be no more than 15,000 words. Original Articles must include an introduction and sections with brief informative subheadings. Use of AI-assisted technologies in the research study or in the writing or presentation of the manuscript should be disclosed in the acknowledgments section.
References Original Articles are encouraged to include no more than 50 references. References may be submitted in any style, though Chicago style is preferred. References must list all authors by first initial(s) and last name, be numbered consecutively in order of first citation, be cited in the text with numbers in square brackets, and all references must be cited in the text.
Figures & Tables Original Articles are encouraged to include no more than 10 figures and/or tables. A single submission file may contain text references figures and tables, or the manuscript may be uploaded as one text file plus separate figure files. Figures and tables must be cited consecutively in the text, every table must have a descriptive title, and the figure identifying number must appear on the same manuscript page as the figure.
Reformat to Cancer Communications using Livewrite Premium

Reviews

Cover Letter A cover letter is required for submission. Cover letter must include the paper title, a brief summary of the main point, a statement that all authors have reviewed and agree to the publication ethics policies, names and email addresses of all authors, one corresponding author designation, and disclosure of any AI-assisted technologies used in the research, writing, or presentation.
Abstract An abstract is required. Abstract must be no more than 350 words. Abstract structure is not specified. No mandatory abstract headings are specified.
Manuscript Reviews should be approximately 3,000 words. Manuscript must include an introduction outlining the main theme, brief subheadings, and an outline of important unresolved questions. Manuscript acknowledgments must note any AI-assisted technologies used in the research, writing, or presentation.
References References may be submitted in any style, though Chicago style is preferred. References must be numbered consecutively in order of first citation, cited in the text using numbers in square brackets, include all authors by first initials and last name without using et al. for omitted authors, and include DOIs when available.
Figures & Tables A single submission file may contain figures and tables, or they may be uploaded separately as one text file plus separate figure files. Figures and tables must be cited consecutively in the text, every table must have a descriptive title, and the figure identifying number must appear on the same manuscript page as the figure.
Reformat to Cancer Communications using Livewrite Premium

Letters

Cover Letter A cover letter is required for submission. Cover letter must include the paper title, a brief summary of the main point, a statement that all authors have reviewed and agree to the publication ethics policies, names and email addresses of all authors, one corresponding author designation, and disclosure of any AI-assisted technologies used in the research, writing, or presentation.
Abstract Letters must not have an abstract.
Manuscript Letters must be no more than 1,200 words excluding references, tables, and figures. Letters must not have subsections such as Introduction, Results, or Discussion. Materials and Methods information should be submitted as supplementary materials when it is important to the study, and any AI-assisted technologies used in the research, writing, or presentation should be noted in the acknowledgments.
References Letters should have 10 references. References may be submitted in any style, though Chicago style is preferred. References must be numbered consecutively in order of first citation, cited in the text with numbers in square brackets, include all authors by initials and last names without using et al. for author lists, and include DOIs when available.
Figures & Tables Letters should have no more than 1 figure or table. Initial submission may be uploaded as a single file containing text, references, figures, legends, tables, and supplementary materials, or as one text file with separate figure and supplementary files. All figures must be cited consecutively in the manuscript, tables must be cited consecutively in the text and have descriptive titles, and figures embedded in Microsoft Word files are not accepted.
Reformat to Cancer Communications using Livewrite Premium

Guidelines

Cover Letter A cover letter is required for submission. Cover letter must include the paper title, a brief summary of the main point, a statement that the material has not been published or submitted elsewhere, confirmation that all authors reviewed and agree to the publication ethics policies, names, email addresses, and ORCID IDs for all authors, and designation of one corresponding author, and it should note any use of AI-assisted technologies.
Abstract An abstract is required. Abstract must contain fewer than 350 words.
Manuscript Manuscript acknowledgments should note any use of AI-assisted technologies.
References References may be submitted in any style, though Chicago style is preferred. References must list all authors by first initial(s) and last name, be numbered consecutively in order of first citation, be cited in the text with numbers in square brackets, include all references cited in the text, use article numbers for journals without page ranges, and include DOIs when available.
Figures & Tables Initial submission may be uploaded as a single file containing text, references, figures and legends, tables and legends, and supplementary materials, or as one text file with separate figure and supplementary files. Figures and tables must be cited consecutively in the manuscript, every table must have a descriptive title, and numerical measurement units in tables must appear in the column headings.
Reformat to Cancer Communications using Livewrite Premium

Recent Publications

Loss of WNT2B Increases Tumor Burden and Malignant Features in Colorectal Cancer

Luiz Fernando Silva Oliveira, Yu-Syuan Wu, Sathuwarman Raveenthiraraj, Jaedeok Kwon, Venkata S. Dasuri, Comfort Adegboye, Juan Putra, Jorge O. Munera, Diana S. Carlone, David T. Breault, Amy E. O'Connell

10.34133/cancomm.0036
View Publication

Hyperprogression after immune checkpoint inhibitors: a cloudy phenomenon with real-life consequences.

Damien Bruyat, Nicolas Girard, Pierre Heudel, Nicolas Penel, Marie Cécile Le Deley, Issaga Diallo, Jean Marie Boher, Christophe Zemmour, Brice Chanez, Anne Madroszyk, Gwenaelle Gravis, Emilien Billon, Aaron Lisberg, Bérénice Collineau, Mathilde Beaufils, Anthony Gonçalves, Manuel Tejeda, Anne-Sophie Chrétien, Philippe Rochigneux

10.34133/cancomm.0035
View Publication

Serplulimab Plus Chemotherapy, With or Without HLX04, Versus Chemotherapy as First-line Treatment for Non-squamous Non-Small-Cell Lung Cancer: Final Survival Analysis of a Randomized, Double-blind, Multicenter Phase III ASTRUM-002 study

Xuezhi Hao, Lin Wang, Yanrong Hao, Yanping Hu, Chun Chen, Bi Chen, Yunchao Huang, Aimin Zang, Yan Wang, Zhendong Chen, Wu Zhuang, Jinsheng Shi, Xiubao Ren, Ligong Nie, Guohua Yu, Feng Luo, Yimin Mao, Xiang Wang, Baolan Li, Yuansong Bai, Jianhua Shi, Hongyan Ni, Xiaoli Hou, Haoyu Yu, Jing Li, Qingyu Wang, Jun Zhu, Yuankai Shi

10.34133/cancomm.0034
View Publication

TGFBR1*6A and risk for colorectal cancer

Allan Moradkhan Johansen, Julie T. Ziegler, Kojo Agyemang, Michael J. Pennison, Hugo Jimenez, Loïc Le Marchand, John L. Hopper, Daniel D. Buchanan, Antonio Di Cristofano, Wencheng Li, Greg Dyson, Ann G. Schwartz, Jennifer L. Beebe-Dimmer, Lara Sucheston-Campbell, Asfar S. Azmi, Sakr Wael, Ralph B. D’Agostino, Carl D. Langefeld, Boris C. Pasche

10.34133/cancomm.0033
View Publication

Institutional Reforms in Drug Review and Approval in China: Reshaping the Landscape of Oncology Drug Development

Ling Tang, Lijia Yuan, Ying Geng, Guo Huang, Zhimin Yang

10.34133/cancomm.0032
View Publication

Frequently asked questions

How long does it take to publish?

Content is published on a continuous basis and is published as soon as production is complete.

Reformat to Cancer Communications using Livewrite Premium

Is a cover letter required?

A cover letter is required. It must include the title of the paper, a brief summary of the main point, a statement that the material has not been published or submitted elsewhere and that all authors agree to the publication ethics policies, and names, email addresses, and ORCID IDs for all authors including the corresponding author.

Reformat to Cancer Communications using Livewrite Premium

What are the publication costs?

Research Topics

Cancer Immunotherapy and Biomarkers Cancer, Hypoxia, and Metabolism Diverse Scientific and Economic Studies Human auditory perception and evaluation Lung Cancer Treatments and Mutations Educational Robotics and Engineering Cancer-related molecular mechanisms research Cancer Cells and Metastasis RNA modifications and cancer Cancer Genomics and Diagnostics Immune cells in cancer Gastric Cancer Management and Outcomes Ferroptosis and cancer prognosis Immunotherapy and Immune Responses Epigenetics and DNA Methylation CAR-T cell therapy research Head and Neck Cancer Studies Esophageal Cancer Research and Treatment Lung Cancer Research Studies Pancreatic and Hepatic Oncology Research Immune Cell Function and Interaction Colorectal Cancer Treatments and Studies Cancer, Lipids, and Metabolism Single-cell and spatial transcriptomics Breast Cancer Treatment Studies

Related Journals

EJ
European Journal of Clinical Investigation WILEY
WM
WIREs Mechanisms of Disease WILEY
IM
Interdisciplinary medicine WILEY
JO
Journal of Clinical Oncology LIPPINCOTT WILLIAMS & WILKINS
AM
Animal Models and Experimental Medicine WILEY
Me
MedComm WILEY